Stephen F. Mahoney - President and CEO, Director at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
VRDN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen F. Mahoney since 10/8/2024

Holdings reported by Stephen F. Mahoney for Viridian Therapeutics, Inc.\DE

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 73.4K $1.72M $23.41 Mar 3, 2025 Direct Common Stock
Common Stock 21.4K $499K $23.33 Sep 27, 2024 Direct
Stock Option (Right to Buy) 441K Mar 3, 2025 Direct Common Stock

Transactions reported by Stephen F. Mahoney for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.